FOLLOW-UP: NIH Lab Identified as Silent Partner in ImmunoMod Atmospheric Program, Raising Ethical Alarms

Following Leak-Social’s initial reporting on the EPA’s classified ImmunoMod atmospheric program, new documents have surfaced linking the National Institutes of Health (NIH) to early-stage development and testing of T-432, the chemical compound at the heart of the aerosol-based immune modulation effort.

A research contract, quietly issued in 2020 under the NIH’s Translational Bioenvironmental Division, awarded $5.2 million to a private biodefense firm to study “airborne immunological regulators” with applications in “population-scale cytokine preconditioning.” Though no mention of T-432 is made in the publicly accessible version of the grant summary, internal correspondence obtained by Leak-Social directly names the compound and outlines key testing goals:

“Evaluate T-432 efficacy in post-mRNA vaccination cohorts. Observe modulation variance by age and prior exposure to lipid-nano carriers.”

The document further details small-scale aerosol field simulations conducted under controlled atmospheric conditions in Nevada and North Carolina. No public disclosures or community notifications were issued prior to the tests.

A senior NIH ethics officer, speaking off-record, expressed concern over the lack of transparency:

“This isn’t environmental science. This is medical experimentation through environmental vectors. And the public didn’t consent to it.”

Of particular concern is the language referencing “co-expression harmonization across immunized populations,” which bioethics analysts say implies an attempt to standardize or manipulate immune system behavior in individuals who received mRNA-based treatments.

Despite the mounting evidence, both the EPA and NIH have refused to publicly comment on the relationship between their agencies and T-432 development. No media outlets have reported on the compound, and no scientific journals have published peer-reviewed studies of its effects.

Meanwhile, a search of the NIH’s internal trial registry yields zero results for “T-432” or any of its listed derivatives.

Leak-Social is actively pursuing contractor lists, aerosol deployment records, and further funding trails linked to ImmunoMod and T-432. Stay with us as we trace this network — because informed consent doesn’t come from the sky.